SMART Use of Medication for the Treatment of Adolescent Severe Obesity

Phase 2 Completed 150 enrolled University of Minnesota National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab

RandomizedSequentialQuadruple-blindTreatment

Summary

This study will examine the timing and sequence of using adjunct obesity pharmacotherapy for adolescents with severe obesity who do not respond to lifestyle modification therapy alone.

Timeline

Start: 2019-11-21
Primary completion: 2025-03-11
Completion: 2025-03-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Phentermine	Small molecule	15 mg	—
Subject	Topiramate	Small molecule	100 mg	—

Indications

No indication recorded.